Nov21

In Brexit aftermath, European Medicines Agency will relocate to Amsterdam

The decision comes at a time of regulatory upheaval in the European Union.

Nov21

Insider error incidents made up majority of breached records in October

According to the latest Protenus Breach Barometer report, there were 37 health data breaches disclosed to HHS or the media in October, impacting 246,246 patient records.

Nov21

Some medical associations are backing away from Outcome Health

The revelation that some Outcome Health employees provided misleading advertising data to customers and a subsequent lawsuit from investors has prompted some medical societies that made deals with the company to back away from the company.

Nov21

FDA treads carefully on molecular diagnostics

FDA approval would set a molecular test apart, said Vince Miller, Foundation Medicine’s chief medical officer. “CLIA is the floor, New York State is a number of floors above that and the FDA is the penthouse.”

Nov21

Medial EarlySign uses machine learning algorithm to predict who is at risk for certain conditions

Founded in 2009, Medial EarlySign is making use of artificial intelligence technology and EHR data to predict which individuals are at risk for specific health conditions.

Nov21

Stepping stones to a new era in gene editing?

After 22 years, gene editing pioneer Sangamo Therapeutics is taking the plunge with three new in vivo gene editing clinical trials. If successful, the studies could serve as a template for myriad other genetic disorders.

Nov21

Mass. Medicaid program seeks power to negotiate drug discounts, exclude meds with little value

Number crunchers say how much would be saved depends on how the state negotiates, how industry responds and what the program covers.

Nov21

Beyond dated models of engagement to a person-centric perspective

How to get people sufficiently motivated to act in a manner that is meaningful to them, that matters or is important enough for them to act is the crux of engagement.